301 related articles for article (PubMed ID: 33595719)
1. The updated view on induced pluripotent stem cells for cardiovascular precision medicine.
Wang Y; Lei W; Yang J; Ni X; Ye L; Shen Z; Hu S
Pflugers Arch; 2021 Jul; 473(7):1137-1149. PubMed ID: 33595719
[TBL] [Abstract][Full Text] [Related]
2. Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.
Pan Z; Ebert A; Liang P
Pflugers Arch; 2021 Jul; 473(7):1151-1165. PubMed ID: 33206225
[TBL] [Abstract][Full Text] [Related]
3. Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling.
Jiang W; Lan F; Zhang H
Curr Stem Cell Res Ther; 2016; 11(7):533-41. PubMed ID: 25322695
[TBL] [Abstract][Full Text] [Related]
4. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
Tzatzalos E; Abilez OJ; Shukla P; Wu JC
Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.
Chen IY; Matsa E; Wu JC
Nat Rev Cardiol; 2016 Jun; 13(6):333-49. PubMed ID: 27009425
[TBL] [Abstract][Full Text] [Related]
6. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
[TBL] [Abstract][Full Text] [Related]
7. Genome Editing and Induced Pluripotent Stem Cell Technologies for Personalized Study of Cardiovascular Diseases.
Chun YW; Durbin MD; Hong CC
Curr Cardiol Rep; 2018 Apr; 20(6):38. PubMed ID: 29666931
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
Tanaka A; Yuasa S; Node K; Fukuda K
Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
[TBL] [Abstract][Full Text] [Related]
9. Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells.
Yang C; Al-Aama J; Stojkovic M; Keavney B; Trafford A; Lako M; Armstrong L
Stem Cells; 2015 Sep; 33(9):2643-51. PubMed ID: 26033645
[TBL] [Abstract][Full Text] [Related]
10. Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.
Khedro T; Duran JM; Adler ED
Curr Cardiol Rep; 2022 Jun; 24(6):631-644. PubMed ID: 35657495
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells in cardiovascular drug discovery.
Mercola M; Colas A; Willems E
Circ Res; 2013 Feb; 112(3):534-48. PubMed ID: 23371902
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific cardiomyocytes for precision medicine: Where are we now?
Zhao MT; Shao NY; Garg V
Stem Cells; 2020 Jul; 38(7):822-833. PubMed ID: 32232889
[TBL] [Abstract][Full Text] [Related]
13. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes.
Karakikes I; Ameen M; Termglinchan V; Wu JC
Circ Res; 2015 Jun; 117(1):80-8. PubMed ID: 26089365
[TBL] [Abstract][Full Text] [Related]
14. Harnessing human genetics and stem cells for precision cardiovascular medicine.
Caudal A; Snyder MP; Wu JC
Cell Genom; 2024 Feb; 4(2):100445. PubMed ID: 38359791
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias.
Gnecchi M; Stefanello M; Mura M
Int J Cardiol; 2017 Jun; 237():49-52. PubMed ID: 28408106
[TBL] [Abstract][Full Text] [Related]
16. Modelling the long QT syndrome with induced pluripotent stem cells.
Itzhaki I; Maizels L; Huber I; Zwi-Dantsis L; Caspi O; Winterstern A; Feldman O; Gepstein A; Arbel G; Hammerman H; Boulos M; Gepstein L
Nature; 2011 Mar; 471(7337):225-9. PubMed ID: 21240260
[TBL] [Abstract][Full Text] [Related]
17. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T; Mummery C; Knollmann BC
Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease models: A game changing paradigm in drug discovery and screening.
Savoji H; Mohammadi MH; Rafatian N; Toroghi MK; Wang EY; Zhao Y; Korolj A; Ahadian S; Radisic M
Biomaterials; 2019 Apr; 198():3-26. PubMed ID: 30343824
[TBL] [Abstract][Full Text] [Related]
19. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.
Ye L; Ni X; Zhao ZA; Lei W; Hu S
J Cardiovasc Transl Res; 2018 Oct; 11(5):366-374. PubMed ID: 29845439
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening.
Sharma A; Wu JC; Wu SM
Stem Cell Res Ther; 2013 Dec; 4(6):150. PubMed ID: 24476344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
